false
0002142627
00-0000000
0002142627
2026-11-12
2026-11-12
0002142627
BHAIU:UnitsEachConsistingOfOneClassOrdinaryShareParValue0.0001PerShareAndOneRightToAcquireOnefourthOfOneClassOrdinaryShareMember
2026-11-12
2026-11-12
0002142627
BHAIU:ClassOrdinarySharesParValue0.0001PerShareMember
2026-11-12
2026-11-12
0002142627
BHAIU:RightsEachRightToAcquireOnefourthOfOneClassOrdinaryShareMember
2026-11-12
2026-11-12
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 12, 2026
| BHAV ACQUISITION CORP II |
| (Exact name of registrant as specified in its charter) |
| Cayman Islands |
|
001-43522 |
|
N/A |
| (State or other jurisdiction |
|
(Commission File Number) |
|
(IRS Employer |
| of incorporation) |
|
|
|
Identification Number) |
255 Old New Brunswick Rd., Suite N210
Piscataway, NJ 08854 |
| (Address of principal executive offices and zip code) |
(732) 612-9552
(Registrant’s telephone number, including
area code)
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act.
| Title of each class |
|
Trading Symbol |
|
Name of each exchange on which registered |
| Units, each consisting of one Class A ordinary share, par value $0.0001 per share, and one right to acquire one-fourth of one Class A ordinary share |
|
BHAIU |
|
The Nasdaq Stock Market LLC |
| Class A ordinary shares, par value $0.0001 per share |
|
BHAI |
|
The Nasdaq Stock Market LLC |
| Rights, each right to acquire one-fourth of one Class A ordinary share |
|
BHAIR |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.02 Unregistered Sales of Equity Securities
The
information included in Item 8.01 of this Current Report on Form 8-K is incorporated into this Item 3.02 by reference to the extent required.
Item 8.01 Other Events.
As previously disclosed on
a Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on November 2, 2026 (the “Previous 8-K”),
BHAV Acquisition Corp II (the “Company”) consummated, on October 30, 2026, its initial public offering (the “IPO”)
of 10,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share, par value $0.0001 per share (each, a
“Class A Ordinary Share”), and one right to receive one-fourth (1/4) of one Class A Ordinary Share upon the completion of
the Company’s initial business combination. The Units were sold at a price of $10.00 per Unit, generating aggregate gross proceeds
to the Company of $100,000,000. The Company granted the underwriters a 45-day option to purchase up to 1,500,000 additional Units to cover
over-allotments, if any. In addition, in connection with the IPO, the Company issued 350,000 Class A Ordinary Shares (the “Representative
Shares”) to the designee of Maxim Group LLC, the representative of the underwriters (the “Representative”), as part
of the underwriting compensation.
As also previously disclosed
in the Previous 8-K, simultaneously with the closing of the IPO, the Company consummated a private placement (a “Private Placement”)
in which BHAV Partners II LLC, the Company’s sponsor (the “Sponsor”), purchased 225,000 units (the “Private Units”)
at a price of $10.00 per unit, for $2,250,000 in the aggregate.
Subsequently, the underwriters
partially exercised the over-allotment option, and the closing of the issuance and sale of the additional Units (the “Over-Allotment
Option Units”) occurred on November 12, 2026. The total aggregate issuance by the Company of 509,855 Over-Allotment Option Units
at a price of $10.00 per unit resulted in total gross proceeds of $5,098,550.00. On November 12, 2026, simultaneously with the sale of
the Over-Allotment Option Units, the Company consummated the private sale of an additional 5,098 Private Units to the Sponsor, generating
gross proceeds of $50,980.00. As a result of the rounding down of the number of additional Private Units purchased by the Sponsor from
5,098.55 to 5,098, the Sponsor also contributed an additional $5.50 to the Company (the “Sponsor Contribution”), such that
the amount held in the trust account equals $10.05 per Class A Ordinary Share sold in the IPO (including the Over-Allotment Option Units).
The Private Units were issued pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and/or Rule 506 of Regulation D promulgated
thereunder, as the transactions did not involve a public offering.
In connection with the underwriters’
partial exercise of the over-allotment option, the Company also issued an additional 17,844 Representative Shares (reflecting the rounding
down of 17,844.925 shares to the nearest whole share) to the designee of the Representative as part of the underwriting compensation relating
to the closing of the over-allotment option and sale and issuance of the Over-Allotment Option Units.
A total of $105,624,042.75
of the net proceeds from the sale of Units in the IPO (including the Over-Allotment Option Units) and the Private Placements on October
30, 2026 and November 12, 2026, and the Sponsor Contribution, were placed in a trust account established for the benefit of the Company’s
public shareholders and the underwriters of the IPO with Continental Stock Transfer & Trust Company, LLC acting as trustee. Of such
amount, $5,124,042.75 ($10.05 per Over-Allotment Option Unit), consisting of (i) $5,073,057.25 of net proceeds from the sale of the Over-Allotment
Option Units, after deducting $25,492.75 of underwriting discounts, (ii) $50,980.00 of proceeds from the sale of the 5,098 additional
Private Units and (iii) the $5.50 Sponsor Contribution, was placed in the trust account on November 12, 2026.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| Exhibit No. |
|
Description of Exhibits |
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
BHAV Acquisition Corp II |
| |
|
|
| |
By: |
/s/ Giri Devanur |
| |
Name: |
Giri Devanur |
| |
Title: |
Chief Executive Officer |
| |
|
|
| Date: November 12, 2026 |
|
|